Aberdeen Group
IMMX icon

Aberdeen Group’s Immix Biopharma IMMX Stock Holding History

Aberdeen Group’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.52M Buy
+818,674
New +$9.27M 0.01% 686

Other funds holding IMMX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
Institute for Wealth Management
Institute for Wealth Management Denver, Colorado $1.13B AUM 31.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Prosperity Capital Advisors
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Aberdeen Group's IMMX Position: Q3 2026 in Review

Aberdeen Group opened a new position in Immix Biopharma (IMMX) in Q3 2026: 818,674 shares worth $8.52M. The stake represents 0.01% of the portfolio and ranks #686 among its holdings.

38 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Aberdeen Group held 818,674 shares of Immix Biopharma worth $8.52M as of Q3 2026.
  • Immix Biopharma was a new Aberdeen Group position in Q3 2026.
  • Immix Biopharma made up 0.01% of Aberdeen Group's portfolio in Q3 2026, its #686 holding.
  • 38 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.